Work

CDK7-Dependent Transcriptional Addiction in Triple-Negative Breast Cancer

Year: 2015

Type: article

Source: Cell

DOI: 10.1016/j.cell.2015.08.063

Authors: Yubao Wang, Tinghu Zhang, Nicholas Kwiatkowski, Brian J. Abraham, Tong Ihn Lee, Shaozhen Xie, Haluk Yuzugullu, Thanh Von, Heyuan Li, Ziao Lin, Daniel G. Stover, Elgene Lim, Zhigang C. Wang, J. Dirk Iglehart, Richard A. Young, Nathanael S. Gray, Jean J. Zhao

Institutions: Harvard University, Dana-Farber Cancer Institute, Whitehead Institute for Biomedical Research, Brigham and Women's Hospital, Dana-Farber Brigham Cancer Center, Massachusetts Institute of Technology, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: Dana-Farber Cancer Institute, National Institutes of Health, National Human Genome Research Institute, National Cancer Institute

Awards: Development and Application of Selective Covalent Cdk7 Inhibitors, Targeting the p110beta Isoform of PI3 Kinase in Pten Null Tumors, Transcriptional Regulatory Networks in Living Cells, Cancer Center Support (Core) Grant, Dana Farber/Harvard Cancer Center Specialized Program of Research Excellence in Breast Cancer

OpenAlex ID: W2149765709

FWCI: 10.55

Cites: 72

Cited by: 464

Related to: 10